Benjamin N Breyer1, Beth E Cohen2, Daniel Bertenthal3, Raymond C Rosen4, Thomas C Neylan5, Karen H Seal2. 1. Department of Urology, University of California, San Francisco, San Francisco, CA. Electronic address: bbreyer@urology.ucsf.edu. 2. Department of Medicine, University of California, San Francisco, San Francisco, CA; Department of Psychiatry, University of California, San Francisco, San Francisco, CA; San Francisco Veterans Affairs Medical Center, San Francisco, CA. 3. San Francisco Veterans Affairs Medical Center, San Francisco, CA. 4. New England Research Institutes, Watertown, MA. 5. Department of Psychiatry, University of California, San Francisco, San Francisco, CA; San Francisco Veterans Affairs Medical Center, San Francisco, CA.
Abstract
OBJECTIVE: To determine the prevalence and correlates of lower urinary tract symptoms (LUTS) among returned Iraq and Afghanistan veterans; in particular its association with mental health diagnoses and medication use. METHODS: We performed a retrospective cohort study of Iraq and Afghanistan veterans who were new users of U.S. Department of Veterans Affairs health care. Mental health diagnoses were defined by International Classification of Disease, 9th Revision, Clinical Modification (ICD-9-CM) codes from medical records. LUTS was defined by ICD-9-CM code, use of prescription medication for LUTS, or procedure for LUTS. We determined the independent association of mental health diagnoses and LUTS after adjusting for sociodemographic and military service characteristics, comorbidities, and medications. RESULTS: Of 519,189 veterans, 88% were men and the mean age was 31.8 years (standard deviation ± 9.3). The overall prevalence of LUTS was 2.2% (11,237/519,189). Veterans with post-traumatic stress disorder (PTSD) were significantly more likely to have a LUTS diagnosis, prescription, or related procedure (3.5%) compared with veterans with no mental health diagnoses (1.3%) or a mental health diagnosis other than PTSD (3.1%, P <.001). In adjusted models, LUTS was significantly more common in veterans with PTSD with and without other mental health disorders vs those without mental health disorders (adjusted relative risk [ARR] = 2.04, 95% confidence interval [CI] = 1.94-2.15) and in veterans prescribed opioids (ARR = 2.46, 95% CI = 2.36-2.56). CONCLUSION: In this study of young returned veterans, mental health diagnoses and prescription for opioids were independently associated with increased risk of receiving a diagnosis, treatment, or procedure for LUTS. Provider awareness may improve the detection and treatment of LUTS, and improve patient care and quality of life.
OBJECTIVE: To determine the prevalence and correlates of lower urinary tract symptoms (LUTS) among returned Iraq and Afghanistan veterans; in particular its association with mental health diagnoses and medication use. METHODS: We performed a retrospective cohort study of Iraq and Afghanistan veterans who were new users of U.S. Department of Veterans Affairs health care. Mental health diagnoses were defined by International Classification of Disease, 9th Revision, Clinical Modification (ICD-9-CM) codes from medical records. LUTS was defined by ICD-9-CM code, use of prescription medication for LUTS, or procedure for LUTS. We determined the independent association of mental health diagnoses and LUTS after adjusting for sociodemographic and military service characteristics, comorbidities, and medications. RESULTS: Of 519,189 veterans, 88% were men and the mean age was 31.8 years (standard deviation ± 9.3). The overall prevalence of LUTS was 2.2% (11,237/519,189). Veterans with post-traumatic stress disorder (PTSD) were significantly more likely to have a LUTS diagnosis, prescription, or related procedure (3.5%) compared with veterans with no mental health diagnoses (1.3%) or a mental health diagnosis other than PTSD (3.1%, P <.001). In adjusted models, LUTS was significantly more common in veterans with PTSD with and without other mental health disorders vs those without mental health disorders (adjusted relative risk [ARR] = 2.04, 95% confidence interval [CI] = 1.94-2.15) and in veterans prescribed opioids (ARR = 2.46, 95% CI = 2.36-2.56). CONCLUSION: In this study of young returned veterans, mental health diagnoses and prescription for opioids were independently associated with increased risk of receiving a diagnosis, treatment, or procedure for LUTS. Provider awareness may improve the detection and treatment of LUTS, and improve patient care and quality of life.
Authors: Adam P Klausner; Tomi Streng; Yong-Gil Na; Jerry Raju; Timothy W Batts; Jeremy B Tuttle; Karl-Erik Andersson; William D Steers Journal: Auton Neurosci Date: 2005-10-26 Impact factor: 3.145
Authors: Mary P Fitzgerald; Carol L Link; Heather J Litman; Thomas G Travison; John B McKinlay Journal: Eur Urol Date: 2007-03-19 Impact factor: 20.096
Authors: Varant Kupelian; John T Wei; Michael P O'Leary; John W Kusek; Heather J Litman; Carol L Link; John B McKinlay Journal: Arch Intern Med Date: 2006-11-27
Authors: William D Steers; Sender Herschorn; Karl J Kreder; Kate Moore; Kris Strohbehn; Ilker Yalcin; Richard C Bump Journal: BJU Int Date: 2007-05-19 Impact factor: 5.588
Authors: Luba W Gourova; Cees van de Beek; Mark G Spigt; Fred H M Nieman; Philip E V A van Kerrebroeck Journal: BJU Int Date: 2006-03 Impact factor: 5.588
Authors: Caroline Selai; Michael S Elmalem; Emmanuel Chartier-Kastler; Natalia Sassoon; Sam Hewitt; Maria Francisca Rocha; Larisa Klitsinari; Jalesh N Panicker Journal: Int Urogynecol J Date: 2022-06-25 Impact factor: 2.894
Authors: Julia Geynisman-Tan; Margaret Helmuth; Abigail R Smith; H Henry Lai; Cindy L Amundsen; Catherine S Bradley; Margaret G Mueller; Christina Lewicky-Gaupp; Steven E Harte; J Eric Jelovsek Journal: Neurourol Urodyn Date: 2021-01-28 Impact factor: 2.696